Nyxoah SA (NYXH) Earnings Call Analysis

NASDAQ · Healthcare · Medical Instruments & Supplies

13/25

Growth 4 Margin 3 Expansion 3 Platform 0 Financial 3

latest quarter score

Earnings Reports

13
Nyxoah (NYXH) Q2 2026: U.S. Net Revenue Jumps 25% as Genio Adoption Expands
July 08, 2026
11
Nyxoah (NYXH) Q1 2026: U.S. Revenue Jumps 25% as Genio Adoption Accelerates
May 13, 2026
14
Nyxoah (NYXH) Q4 2025: U.S. Genio Launch Drives 122% Revenue Growth, Sales Force Expands to 40
March 20, 2026
12
Nyxoah (NYXH) Q3 2025: U.S. Genio Launch Drives 56% Revenue Surge, Signals Commercial Inflection
November 14, 2025
9
NextL (NYXH) Q2 2025: Genio US Launch Accelerates With 74% Revenue Growth and Differentiated Label
August 18, 2025
9
Nyxoah (NYXH) Q1 2025: U.S. Commercial Team Doubles as FDA Approval Nears
July 03, 2025
14
Nyxoah (NYXH) Q4 2024: 46% Sequential Revenue Growth Excluding Deferred Revenue Signals U.S. Launch Momentum
March 13, 2025

Browse all companies